Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05203328 · ClinicalTrials.gov registry record · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
A NA study of Lung Cancer, sponsored by The Cooper Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 198
- Enrollment target
- 1
- Study location
NCT05203328: Recruiting NA study of Lung Cancer, sponsored by The Cooper Health System.
NCT05203328 is a NA study of Lung Cancer that is actively recruiting participants, run by The Cooper Health System. The registered enrollment target is 198 participants, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05203328, a NA study of Lung Cancer, is actively recruiting participants, sponsored by The Cooper Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 198 participants
- Enrollment target
- 1
- Study location
Study Summary
Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.
Conditions Studied
Interventions
- DEVICE Vapotherm
- DEVICE Regular nasal canula
Study Locations (1)
New Jersey
- Cooper University Hospital - Camden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2022-02-01 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05203328
The ClinicalTrials.gov registry entry for NCT05203328 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 935-participant average among 409 other Lung Cancer trials with a reported enrollment target (79% lower). The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Vapotherm is the first listed.
NCT05203328 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT05203328 about?
NCT05203328 is a clinical study titled "Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy". Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes a...
What is the current status of trial NCT05203328?
This trial is currently recruiting. It is a NA study. The enrollment target is 198 participants. The study started on 2022-02-01. Estimated completion is 2026-05.
What conditions does trial NCT05203328 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT05203328?
The interventions under investigation include: Vapotherm (DEVICE), Regular nasal canula (DEVICE).
Who is sponsoring clinical trial NCT05203328?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05203328 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.